Mitochondrial dynamics, mitophagy and cardiovascular disease
Vásquez-Trincado C1, García-Carvajal I, Pennanen C, Parra V, Hill JA, Rothermel BA, Lavandero S2.
TonEBP suppresses IL-10-mediated immunomodulation.
Choi SY1, Lee HH, Lee JH, Ye BJ, Yoo EJ, Kang HJ, Jung GW, An SM, Lee-Kwon W, Chiong M, Lavandero S, Kwon HM2
Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Morales CR1, Li DL, Pedrozo Z, May HI, Jiang N, Kyrychenko V, Cho GW, Kim SY, Wang ZV, Rotter D, Rothermel BA, Schneider JW, Lavandero S, Gillette TG, Hill JA2.
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Klionski DJ3,Abdelmohsen K, Lavandero S, Pedrozo Z, Troncoso R et al.
FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation.
Vivar R1, Humeres C, Muñoz C, Boza P2, Bolivar S, Tapia F, Lavandero S, Chiong M2, Diaz-Araya G2.
Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
Riquelme JA1, Westermeier F, Hall AR, Vicencio JM, Pedrozo Z, Ibacache M, Fuenzalida B, Sobrevia L, Davidson SM, Yellon DM, Sánchez G2, Lavandero S2.
